agilon health

AGL

----

Current ValuationThe current P/E ratio is -6.53, within the reasonable range, cheaper than 40.06% of the time in the past 5 years, and the industry ranks 46/74, the industry Median --.

-6.53xP/E

Stock price$90.29Earnings per share$-13.83

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

07142128

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x40x80x120x160x200x

P/E ratio
Name/Symbol
GHUSGuardant Health	-48.22x	3.12%	$21.87B
HIMSUSHims & Hers Health	-47.85x	209.86%	$6.80B
RDNTUSRadnet	-261.85x	128.00%	$5.53B
NEOUSNeogenomics	-40.59x	64.12%	$2.11B
WGSUSGeneDx	-18.83x	359.59%	$2.00B
AGLUSagilon health	-6.53x	92.48%	$1.52B
INNVUSInnovage	-512.03x	2,301.70%	$1.30B
OPKUSOpko Health	-16.69x	25.99%	$1.22B
LMRIUSLumexa Imaging	-37.73x	145.51%	$1.05B
CSTLUSCastle Biosciences	-52.22x	51.54%	$1.01B
AONCUSAmerican Oncology Network	--	--	$745.50M
GMRSUSGMR Solutions	-7.69x	91.45%	$581.81M
FLGTUSFulgent Genetics	-6.52x	42.64%	$550.03M
PREUSPrenetics Global	-6.04x	15.02%	$284.07M
BDSXUSBiodesix	-9.10x	42.77%	$252.59M
GAMGUSGlobal Asset Management Group, Inc.	-351.59x	--	$198.45M
NAKAUSNakamoto	-0.33x	102.50%	$137.61M
CORBFUSGlobal Cord Blood Corporation	--	--	$127.35M
PARKUSPark Dental Partners	-27.23x	--	$96.25M
AIRSUSAirSculpt Tech	-7.68x	33.33%	$90.12M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.